|
|
Post by mnkdfann on Jun 13, 2017 23:03:47 GMT -5
My bust. It's my Yahoo app stock portolio MNKD chart that still did not adjust for the split that shows a high of 2.38 in the past 52 weeks and the current 1.43 now. I get so confused 😩 I noticed that too stay away from yahoo So much is wrong with / at yahoo finance nowadays. Especially the so-called 'improvements' they made a while back. It seems they just don't care. A shame, as it used to be such a great resource. |
|
|
|
Post by peppy on Jun 15, 2017 9:48:47 GMT -5
real time nasdaq volume.
Tuesday 6/13 212,533 in the first hour $1.52, 1,383,847 end of day $1.43
Wednesday 6/14 262,655 the first 10 mins, 331,709 the first 1/2 hour $1.41, 996,773 at the half, 1,671,921 end of day $1.36.
today, open 126,042 in 5 mins $1.32, 15 min 176,020 $1.35 presently trading at $1.38 on 313,634 shares in 1 hour and 15 min.
I type this since today is expiry. Guess what price it is best for the CBOE to make money on their option sales? my guess is $1.38.
|
|
|
|
Post by peppy on Jun 15, 2017 12:34:34 GMT -5
real time nasdaq volume. Tuesday 6/13 212,533 in the first hour $1.52, 1,383,847 end of day $1.43 Wednesday 6/14 262,655 the first 10 mins, 331,709 the first 1/2 hour $1.41, 996,773 at the half, 1,671,921 end of day $1.36. today, open 126,042 in 5 mins $1.32, 15 min 176,020 $1.35 presently trading at $1.38 on 313,634 shares in 1 hour and 15 min. I type this since today is expiry. Guess what price it is best for the CBOE to make money on their option sales? my guess is $1.38. todays volume so far 4 hour volume, 618,783 plus 6 cents. $1.42. www.nasdaq.com/symbol/mnkd/real-time
Close those puts?
price close to a downtrend line, that if prices crosses, $1.54 targets. Not saying it is going to happen, just that the pattern it there.
|
|
|
|
Post by peppy on Jun 15, 2017 15:06:33 GMT -5
|
|
|
|
Post by peppy on Jun 16, 2017 8:46:00 GMT -5
The $1.54 target hit. On heavy volume, 414,269 shares in 5 mins. plenty of resistance at $1.56.
through $1.56, $1.63, $1.68. remember all the resistance at $1.64ish.
looking more closely, through $1.77, price can move up again.
509,129 shares in 15 mins. volume slowed a bit. Let's see.
|
|
|
|
Post by hiswelshness on Jun 16, 2017 12:45:21 GMT -5
Hey guys! What thread here discusses weekly rx #'s. Thank you in advance.
|
|
|
|
Post by porkini on Jun 16, 2017 12:51:30 GMT -5
|
|
|
|
Post by peppy on Jun 16, 2017 13:31:44 GMT -5
do you all see the break out? I do.
|
|
|
|
Post by peppy on Jun 16, 2017 15:09:26 GMT -5
|
|
|
|
Post by Omega on Jun 16, 2017 16:17:50 GMT -5
do you all see the break out? I do.
Looks like the Sales $$$ is the Highest its been since Jan 1st 2016 ! Back then it took 516 Scripts for SNY to reach $278k. |
|
|
|
Post by seanismorris on Jun 16, 2017 17:42:01 GMT -5
Still not good enough.
We need considerably faster growth. I was looking for 1500-2000 scripts by September.
I want MannKind to be profitable by the end of next year.
*No one should be cheering yet
I expect dilution this year, if it's the last time EVER maybe we can dig ourselves out of this hole.
|
|
|
|
Post by saxcmann on Jun 16, 2017 17:50:31 GMT -5
Still not good enough. We need considerably faster growth. I was looking for 1500-2000 scripts by September. I want MannKind to be profitable by the end of next year. *No one should be cheering yet I expect dilution this year, if it's the last time EVER maybe we can dig ourselves out of this hole. l agree with everything you said besides the dilution part. I pray you're wrong and Mike finds another way to increase runway for 18-24 months...partner or international deal(s), etc. You could be right and shorts win again. 😠 |
|
|
|
Post by wgreystone on Jun 16, 2017 18:14:06 GMT -5
Still not good enough. We need considerably faster growth. I was looking for 1500-2000 scripts by September. I want MannKind to be profitable by the end of next year. *No one should be cheering yet I expect dilution this year, if it's the last time EVER maybe we can dig ourselves out of this hole. l agree with everything you said besides the dilution part. I pray you're wrong and Mike finds another way to increase runway for 18-24 months...partner or international deal(s), etc. You could be right and shorts win again. 😠 Dilution is not an issue. If MNKD can find investors to put new money in, that is a good thing. MNKD needs to show what strategy will bring in new revenue. The new sales team hasn't made much change yet. Will DTC work? Will international parternship brings in new revenue soon? Or will OneDrop partnership bring Afrezza directly to PWD (bypassing the reluctant doctors)? |
|
|
|
Post by agedhippie on Jun 17, 2017 15:36:21 GMT -5
l agree with everything you said besides the dilution part. I pray you're wrong and Mike finds another way to increase runway for 18-24 months...partner or international deal(s), etc. You could be right and shorts win again. 😠 Dilution is not an issue. If MNKD can find investors to put new money in, that is a good thing. MNKD needs to show what strategy will bring in new revenue. The new sales team hasn't made much change yet. Will DTC work? Will international parternship brings in new revenue soon? Or will OneDrop partnership bring Afrezza directly to PWD (bypassing the reluctant doctors)? Dilution is an issue. There are a lot of shorts waiting for it. - Will DTC work? Depends what you expect DTC to deliver. I am deeply unconvinced personally that it will trigger a sharp rise in script since I see it as easy for a doctor to talk the patient around. What it will do is raise awareness and visibility which will help in the long run. - International partnership bringing in new revenue soon? Not going to happen to any significant extent. Afrezza would have to be competitively priced and those numbers are a fraction of the US. Couple that with needing to build up the market, and getting doctors on-board. New revenue - yes, soon - no. - One Drop delivering Afrezza direct to PWD bypassing doctor. That requires a change in the law or the classification of Afrezza. Neither of those is going to happen. What I expect to happen is a repeat of the last Deerfield settlement with the debt settled part in cash and part in stock. Some dilution, some cash preservation. |
|
|
|
Post by gamblerjag on Jun 17, 2017 16:58:06 GMT -5
Dilution is not an issue. If MNKD can find investors to put new money in, that is a good thing. MNKD needs to show what strategy will bring in new revenue. The new sales team hasn't made much change yet. Will DTC work? Will international parternship brings in new revenue soon? Or will OneDrop partnership bring Afrezza directly to PWD (bypassing the reluctant doctors)? Dilution is an issue. There are a lot of shorts waiting for it. - Will DTC work? Depends what you expect DTC to deliver. I am deeply unconvinced personally that it will trigger a sharp rise in script since I see it as easy for a doctor to talk the patient around. What it will do is raise awareness and visibility which will help in the long run. - International partnership bringing in new revenue soon? Not going to happen to any significant extent. Afrezza would have to be competitively priced and those numbers are a fraction of the US. Couple that with needing to build up the market, and getting doctors on-board. New revenue - yes, soon - no. - One Drop delivering Afrezza direct to PWD bypassing doctor. That requires a change in the law or the classification of Afrezza. Neither of those is going to happen. What I expect to happen is a repeat of the last Deerfield settlement with the debt settled part in cash and part in stock. Some dilution, some cash preservation. . Age. With all the new hires the new show one drop. we know UAE is in play Mike not appearing worried I give dilution about a 5% chance at this point. We have turned the corner |
|
